Diagnostic method for the determination of cardiovascular functionality of specific progenitor cells

With assistance of the inventive method patients can be identified showing low capacity of neo-vascularisation of their stem and progenitor cells which would weaken the success of cell therapy. At the same time the method identifies patients with increased infarct risk.

Further Information: PDF

INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/798-49721

Contact
Dr. Otmar Schöller

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Why getting in touch with our ‘gerbil brain’ could help machines listen better

Macquarie University researchers have debunked a 75-year-old theory about how humans determine where sounds are coming from, and it could unlock the secret to creating a next generation of more…

Attosecond core-level spectroscopy reveals real-time molecular dynamics

Chemical reactions are complex mechanisms. Many different dynamical processes are involved, affecting both the electrons and the nucleus of the present atoms. Very often the strongly coupled electron and nuclear…

Free-forming organelles help plants adapt to climate change

Scientists uncover how plants “see” shades of light, temperature. Plants’ ability to sense light and temperature, and their ability to adapt to climate change, hinges on free-forming structures in their…

Partners & Sponsors